NCT00038025View on ClinicalTrials.gov

A Study Of Deoxycoformycin(DCF)/Pentostatin In Lymphoid Malignancies

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 6, 1994

Primary Completion Date

November 29, 2006

Study Completion Date

November 29, 2006

Conditions
Peripheral T-cell LymphomaCutaneous T-cell LymphomaChronic Lymphocytic Leukemia
Interventions
DRUG

Deoxycoformycin (DCF)

Patients received Deoxycoformycin (DCF)/Pentostatin administered by intravenous bolus daily over a consecutive 3-day period. This course was repeated at 3-week intervals.

Trial Locations (1)

77030

M. D. Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER